Suchergebnisse - "Hyun, Hak Jun"

PubPharm (17)

1

Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines : a nationwide cohort study using an emulated target trial approach

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Choi, M. | Na, Y. | Hyun, H. | +10

2

Assessment of Disease Burden and Immunization Rates for Vaccine-Preventable Diseases in People Living with HIV : The Korea HIV/AIDS Cohort Study

enthalten in: Infection & chemotherapy | 2023

von Seong, H. | Choi, Y. | Ahn, K. | +12

3

Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination : Analysis of National Health Insurance Database

enthalten in: The Journal of infectious diseases | 2023

von Yoon, J. | Kim, Y. | Choi, M. | +11

4

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients : Comparison by the Types of Prior Infection and Vaccine Formulations

enthalten in: Vaccines | 2023

von Hyun, H. | Choi, M. | Nham, E. | +11

5

Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA vaccine heterologous boost

enthalten in: Vaccine | 2023

von Kim, W. | Roberts, C. | Song, J. | +16

6

Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Kim, W. | Roberts, C. | Song, J. | +21

7

Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis

enthalten in: Frontiers in immunology | 2023

von Seong, H. | Kim, J. | Han, Y. | +9

8

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment

enthalten in: The Journal of infection | 2022

von Yoon, J. | Yoo, J. | Lee, J. | +12

CommentIn: J Infect. 2022 Aug;85(2):174-211. - PMID 35513188

9

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19 : A Randomized, Open-Label, Phase 2 Trial

enthalten in: Journal of clinical medicine | 2021

von Song, J. | Yoon, J. | Seo, Y. | +11

10

Risk factors for SARS-CoV-2 transmission in non-household clusters

enthalten in: The Journal of infection | 2021

von Noh, J. | Song, J. | Hyun, H. | +7

CommentOn: J Infect. 2020 Oct;81(4):621-624. - PMID 32735893